As of 2023, the cervix uteri cancer screening coverage in France stood at a slightly higher level than the forecasted values, indicating a gradual decline over the upcoming years. The forecast from 2024 to 2028 suggests stability with a marginal downward shift, featuring coverage rates starting at 58.6% in 2024, mildly dropping to 58.3% by 2028.
For future trends, attention should be focused on healthcare policy changes, public health campaigns, and technological advancements in screening processes that could potentially bolster the uptake in screenings. Additionally, societal awareness and accessibility initiatives could also impact these trends positively.
